Loading clinical trials...
Loading clinical trials...
Sleep apnea including obstructive sleep apnea (OSA) and central sleep apnea (CSA), are common in patients with cardiovascular disease. The prevalence of OSA is 2%-4% in general population and 16%-47% ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Nanjing Medical University
NCT06430957 · Obstructive Sleep Apnea Risk Management, Postoperative Complications, and more
NCT05208567 · Heart Valve Diseases, Left Ventricular Dysfunction
NCT05289063 · Obstructive Sleep Apnea of Adult
NCT03307330 · Obstructive Sleep Apnea of Adult
NCT07390903 · Cardiopulmonary Bypass, Coronary Artery Bypass, and more
the First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions